Does this optic neuritis patient have neuromyelitis optica? An approach to optic neuritis in the context of neuromyelitis optica

被引:1
作者
Burton, Jodie M. [1 ,2 ,3 ,4 ]
Costello, Fiona [1 ,2 ,3 ,5 ]
机构
[1] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada
[2] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada
[3] Univ Calgary, Calgary, AB, Canada
[4] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[5] Univ Calgary, Dept Surg Ophthalmol, Calgary, AB, Canada
关键词
aquaporin-4; demyelinating disease; Devic's disease; immunosuppression; myelopathy; neuromyelitis optica; neuromyelitis optica spectrum disorder; NMO-IgG; optic neuritis; rituximab;
D O I
10.1586/17469899.2014.922874
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Optic neuritis is a common presentation of demyelinating disease, most often associated with multiple sclerosis, and typically associated with a relatively good recovery and prognosis. However, when optic neuritis is the heralding event of neuromyelitis optica (NMO), it is much more likely to be the start of a devastating and disabling chronic disease with a reduced lifespan. Early recognition of NMO is the best chance a patient has of avoiding life-altering disability, as relapse prevention is essentially disability prevention because this disease, unlike MS, does not really have a progressive component. The following review was written to assist the clinician, particularly the ophthalmologist, in assessing optic neuritis in evaluating and recognizing the potential NMO patient.
引用
收藏
页码:205 / 216
页数:12
相关论文
共 78 条
  • [31] Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
    Jarius, Sven
    Ruprecht, Klemens
    Wildemann, Brigitte
    Kuempfel, Tania
    Ringelstein, Marius
    Geis, Christian
    Kleiter, Ingo
    Kleinschnitz, Christoph
    Berthele, Achim
    Brettschneider, Johannes
    Hellwig, Kerstin
    Hemmer, Bernhard
    Linker, Ralf A.
    Lauda, Florian
    Mayer, Christoph A.
    Tumani, Hayrettin
    Melms, Arthur
    Trebst, Corinna
    Stangel, Martin
    Marziniak, Martin
    Hoffmann, Frank
    Schippling, Sven
    Faiss, Juergen H.
    Neuhaus, Oliver
    Ettrich, Barbara
    Zentner, Christian
    Guthke, Kersten
    Hofstadt-van Oy, Ulrich
    Reuss, Reinhard
    Pellkofer, Hannah
    Ziemann, Ulf
    Kern, Peter
    Wandinger, Klaus P.
    Bergh, Florian Then
    Boettcher, Tobias
    Langel, Stefan
    Liebetrau, Martin
    Rommer, Paulus S.
    Niehaus, Sabine
    Muench, Christoph
    Winkelmann, Alexander
    Zettl U, Uwe K.
    Metz, Imke
    Veauthier, Christian
    Sieb, Joern P.
    Wilke, Christian
    Hartung, Hans P.
    Aktas, Orhan
    Paul, Friedemann
    [J]. JOURNAL OF NEUROINFLAMMATION, 2012, 9
  • [32] AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
    Jarius, Sven
    Wildemann, Brigitte
    [J]. NATURE REVIEWS NEUROLOGY, 2010, 6 (07) : 383 - 392
  • [33] Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis
    Khanna, Sangeeta
    Sharma, Aseem
    Huecker, Julie
    Gordon, Mae
    Naismith, Robert T.
    Van Stavern, Gregory P.
    [J]. JOURNAL OF NEURO-OPHTHALMOLOGY, 2012, 32 (03) : 216 - 220
  • [34] Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica Implication for Cellular Immune Responses
    Kieseier, Bernd C.
    Stueve, Olaf
    Dehmel, Thomas
    Goebels, Norbert
    Leussink, Verena I.
    Mausberg, Anne K.
    Ringelstein, Marius
    Turowski, Bernd
    Aktas, Orhan
    Antoch, Gerald
    Hartung, Hans-Peter
    [J]. JAMA NEUROLOGY, 2013, 70 (03) : 390 - 393
  • [35] A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder
    Kim, Su-Hyun
    Huh, So-Young
    Lee, Sun Ju
    Joung, Aeran
    Kim, Ho Jin
    [J]. JAMA NEUROLOGY, 2013, 70 (09) : 1110 - 1117
  • [36] Clinical Efficacy of Plasmapheresis in Patients with Neuromyelitis Optica Spectrum Disorder and Effects on Circulating Anti-Aquaporin-4 Antibody Levels
    Kim, Su-Hyun
    Kim, Woojun
    Huh, So-Young
    Lee, Kyue Yim
    Jung, In Ja
    Kim, Ho Jin
    [J]. JOURNAL OF CLINICAL NEUROLOGY, 2013, 9 (01): : 36 - 42
  • [37] Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years
    Kim, Su-Hyun
    Kim, Woojun
    Li, Xue Feng
    Jung, In-Ja
    Kim, Ho Jin
    [J]. ARCHIVES OF NEUROLOGY, 2011, 68 (11) : 1412 - 1420
  • [38] Efficacy and Safety of Mitoxantrone in Patients With Highly Relapsing Neuromyelitis Optica
    Kim, Su-Hyun
    Kim, Woojun
    Park, Min Su
    Sohn, Eun Hee
    Li, Xue Feng
    Kim, Ho Jin
    [J]. ARCHIVES OF NEUROLOGY, 2011, 68 (04) : 473 - 479
  • [39] Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder
    Kim, Woojun
    Kim, Su-Hyun
    Huh, So-Young
    Kim, Ho Jin
    [J]. MULTIPLE SCLEROSIS INTERNATIONAL, 2012, 2012
  • [40] NMO-IgG detected in CSF in seronegative neuromyelitis optica
    Klawiter, E. C.
    Alvarez, E., III
    Xu, J.
    Paciorkowski, A. R.
    Md, L. Zhu
    Parks, B. J.
    Cross, A. H.
    Naismith, R. T.
    [J]. NEUROLOGY, 2009, 72 (12) : 1101 - 1103